Перейти
на сайт журнала "Врач" |
Перейти на сайт журнала "Медицинская сестра"
|
Перейти на сайт журнала "Фармация"
|
Перейти на сайт журнала "Молекулярная медицина"
|
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"
|
Журнал включен в российские и международные библиотечные и реферативные базы данных
ВАК (Россия)
|
РИНЦ (Россия)
|
Эко-Вектор (Россия)
|
INFLUENCE 3-FORMYLCHROMONE DERIVATIVES IN VITRO AT AGGREGATION OF Β-AMYLOID PLAGUES AND TYROSINASE ACTIVITY
DOI: https://doi.org/10.29296/25877313-2021-01-02
Issue:
1
Year:
2021
Objectives. Alzheimer's disease is one of the most common terminal forms of dementia, characterized by a complex pathogenesis with the for-mation of amyloid plaques in the brain structures. At the same time, one of the new and promising areas of Alzheimer's disease therapy is the influ-ence on the amyloidogenic cascade. Aim of the study. In vitro to evaluate the effect of ten 3-formylchromone derivatives on the formation of β-amyloid aggregates and tyrosinase activity. Materials and methods. The effect of the studied compounds on tyrosinase activity was evaluated using the Mapunyamethod, using L-tyrosine as a substrate and kojic acid as a reference. Aggregation of amyloid plaqueswas studied spectrophotometrically in reaction with Congo red after three and six days of incubation. Results. Among the test-objects, the most significant antithyrosinase properties were found in the 6-acetyl substituted derivative of 3-formylchromone, whose IC50 value was comparable to kojic acid (32±1.913 µg/ml versus 30.2±1.599 µg/ml). Also, this compound most significant-ly inhibited the aggregation of amyloid plaques on the third day of incubation–31.0% (p
Keywords:
Alzheimer's disease
chromone derivatives
tyrosinase
β-amyloid
References:
- Takizawa C., Thompson P.L., van Walsem A., et al. Epidemiological and economic burden of Alzheimer's disease: a systematic literature review of data across Europe and the United States of America. J Alzheimers Dis. 2015; 43(4):1271–84. 10.3233/JAD-141134
- Prince M., Wimo A.,Guerchet M., Gemma Claire Ali, Yu-Tzu Wu, Matthew A. Prina. World Alzheimer Report 2015. The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. 2015.
- Kerr J.S., Adriaanse B.A., Greig N.H. et al. Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms. Trends Neurosci. 2017;40(3):151-166. doi:10.1016/j.tins.2017.01.002
- Mattson M.P. Pathways towards and away from Alzheimer’s disease. Nature. 2004; 430(7000):631–639.
- Wang R., Tang P., Wang P., Boissy R.E., Zheng H. Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation. Proc Natl. Acad. Sci. USA. 2006; 103(2):-353-358. doi:10.1073/pnas.0509822102
- Arbor S.C., La Fontaine M., Cumbay M. Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores. Yale J. Biol. Med. 2016; 89(1):5-21.
- Mapunya M.B., Nikolova R.V., Lall N. Melanogenesis and antityrosinase activity of selected South african plants. Evid. Based Complement Alternat. Med. 2012; 2012: 374017. doi:10.1155/2012/374017
- Wang W., Zhao C., Zhu D., Gong G., Du W. Inhibition of amyloid peptide fibril formation by gold-sulfur complexes. J Inorg. Biochem. 2017; 171:1-9. doi:10.1016/j.jinorgbio.2017.02.021
- Esquerda-Canals G., Montoliu-Gaya L.,Güell-Bosch J., Villegas S. Mouse Models of Alzheimer's Disease. J. Alzheimersju Dis. 2017; 57(4):1171-1183. doi:10.3233/JAD-170045
- De Biase D., Costagliola A., Pagano T.B., et al. Amyloid precursor protein, lipofuscin accumulation and expression of autophagy markers in aged bovine brain. BMC Vet. Res. 2017; 13(1):102. doi:10.1186/s12917-017-1028-1
- Ohm T.G., Braak H. The pigmented subpeduncular nucleus: a neuromelanin-containing nucleus in the human pontine tegmentum. Morphology and changes in Alzheimer's disease. Acta Neuropathol. 1988; 77(1):26-32. doi:10.1007/BF00688239